NANOSPHERE INC
IT consulting and strategic guidance services
- Sector
- Software
- Headquarters
- NORTHBROOK, IL
- Latest Form D
- $4.1M, May 2015
- Total capital
- $7M
- Federal grants
- $3M
- 11 awards · 2000–2007
- Sector median 0 awards
- Private capital raised
- $4.1M
- 1 Form D · last May 2015
- 137 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 7
- 33 pending · first 2017
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$4.1M
- Federal grantHealth and Human S · Phase I · A Novel Diagnostic Test for Clostridium difficile-Associated Diarrhea (CDAD)$291K
- Federal grantHealth and Human S · Phase II · Nanoparticle Probe Assay for Biological Threat Agents$375K
- Federal grantHealth and Human S · Phase II · Nanoparticle Probe Assay for Biological Threat Agents$375K
- Federal grantHealth and Human S · Phase I · Nanoparticle Probe Assay for Biological Threat Agents$100K
- Federal grantHealth and Human S · Phase I · Staphylococcus And Methicillin Resistance Assay$100K
- Federal grantHealth and Human S · Phase II · An Assay For Genetic Mutations Causing Hypercoagulation$422K
Show 5 earlier federal awards
- Federal grantHealth and Human S · Phase II · An Assay For Genetic Mutations Causing Hypercoagulation$344K
- Federal grantHealth and Human S · Phase I · An Assay For Genetic Mutations Causing Hypercoagulation$100K
- Federal grantHealth and Human S · Phase II · Rapid Assay for the l1307K Mutation of the APC Gene$504K
- Federal grantHealth and Human S · Phase II · Rapid Assay for the l1307K Mutation of the APC Gene$264K
- Federal grantHealth and Human S · Phase I · Rapid Assay For The I1307K Mutation Of The Apc Gene$100K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
182months
from NANOSPHERE INC’s first federal award to its first private round.
- First federal award · Mar 2000
- Health and Human S · $100K
- First Form D · May 2015
- $4.1M · 1st Form D
- Awards before first raise
- 11 awards
An association in public records, not a cause or a prediction.
Founders and team
From SEC Form D filings- Andre K. de BruinDirectorNamed in SEC Form D filings
- Ann K. WallinExecutive OfficerNamed in SEC Form D filings
- Erik K. HolmlinDirectorNamed in SEC Form D filings
- Gene K. CartwrightDirectorNamed in SEC Form D filings
- Kenneth K. BahkExecutive OfficerNamed in SEC Form D filings
- Kristopher A. WoodDirectorNamed in SEC Form D filings
Show all 9 people
- Lorin J. RandallDirectorNamed in SEC Form D filings
- Michael K. McGarrityExecutive Officer, DirectorNamed in SEC Form D filings
- Michael J. WardDirectorNamed in SEC Form D filings
What it has protected
USPTO · 7 granted of 40- PendingMethods of Treating Inflammatory Disorders and Global Inflammation with Compositions Comprising Phospholipid Nanoparticle Encapsulations of Anti-Inflammatory NutraceuticalsUSPTOApplication 18225585
- GrantedMethods of Treating Inflammatory Disorders and Global Inflammation with Compositions Comprising Phospholipid Nanoparticle Encapsulations of NSAIDSUSPTOUS 11,707,436
- PendingLipid Nanoparticle Compositions And Methods As Carriers Of Cannabinoids In Standardized Precision-metered Dosage FormsUSPTOApplication 17841672
Show all 40 patent records
- Methods of Treating Inflammatory Disorders and Global Inflammation with Compositions Comprising Phospholipid Nanoparticle Encapsulations of Anti-Inflammatory NutraceuticalsMar 7, 2024 · Application 18225585Pending
- Methods of Treating Inflammatory Disorders and Global Inflammation with Compositions Comprising Phospholipid Nanoparticle Encapsulations of NSAIDSJul 25, 2023 · US 11,707,436Granted
- Lipid Nanoparticle Compositions And Methods As Carriers Of Cannabinoids In Standardized Precision-metered Dosage FormsSep 29, 2022 · Application 17841672Pending
- Diagnostic Cartridges Having Flexible SealsSep 28, 2021 · US 11,130,137Granted
- Lipid Nanoparticle Compositions And Methods As Carriers Of Cannabinoids In Standardized Precision-metered Dosage FormsJul 30, 2020 · Application 16827601Pending
- Lipid Nanoparticle Compositions And Methods As Carriers Of Cannabinoids In Standardized Precision-metered Dosage FormsMar 24, 2020 · US 10,596,124Granted
- Diagnostic Cartridges Having Flexible SealsOct 9, 2018 · US 10,092,906Granted
- Lipid Nanoparticle Compositions And Methods As Carriers Of Cannabinoids In Standardized Precision-metered Dosage FormsJul 24, 2018 · US 10,028,919Granted
- Nanoparticle Compositions and Methods as Carriers of Nutraceutical Factors Across Cell Membranes and Biological BarriersMar 27, 2018 · US 9,925,149Granted
- Diagnostic Cartridges Having Flexible SealsNov 28, 2017 · US 9,827,567Granted
- Method Of Denaturing And Fragmenting Dna Or Rna Using UltrasoundApplication PCTUS2007016659Pending
- System Using Disposable Self-contained Processing Module For Detecting Nucleic AcidsApplication PCTUS2007016650Pending
- A Non-nucleic Acid Based Biobarcode Assay For Detection Of Biological MaterialsApplication PCTUS2007011450Pending
- Methods For Preparing Hybrid Substrates Comprising Dna And Antibodies And Uses ThereofApplication PCTUS2006032301Pending
- Selective Isolation And Concentration Of Nucleic Acids From Complex SamplesApplication PCTUS2006024761Pending
- Substrate Functionalization Method For High Sensitivity ApplicationsApplication PCTUS2006019339Pending
- Biobarcode Assays For Ultra High Sensitive DetectionApplication PCTUS2006019170Pending
- Method For Detecting A Target AnalyteApplication PCTUS2006011033Pending
- Method For Detecting Analytes Based On Evanescent Illumination And Scatter-based Detection Of Nonoparticle Probe ComplexesApplication PCTUS2005042326Pending
- Method For Distinguishing Methicillin Resistant S. Aureus From Methicillin Sensitive S. Aureus In A Mixed CultureApplication PCTUS2005026578Pending
- Bio-barcode Based Detection Of Target AnalytesApplication PCTUS2005016545Pending
- Method For Preparing Substrates Having Immobilized Molecules And SubstratesApplication PCTUS2005016134Pending
- Aptamer-nanoparticle Conjugates And Method Of Use For Target Analyte DetectionApplication PCTUS2005016201Pending
- Nanoparticle Imaging System And MethodApplication PCTUS2005001011Pending
- Method Of Preparing Nucleic Acids For DetectionApplication PCTUS2004036959Pending
- Bio-barcode Based Detection Of Target AnalytesApplication PCTUS2004020493Pending
- Method For Detecting Analytes Based On Evanescent Illumination And Scatter-based Detection Of Nanoparticle Probe ComplexesApplication PCTUS2004016656Pending
- Direct Snp Detection With Unamplified DnaApplication PCTUS2003039836Pending
- Nanoparticle Polyanion Conjugates And Methods Of Use Thereof In Detecting AnalytesApplication PCTUS2003021021Pending
- Electrical Detection Of Dna Hybridization And Specific Binding EventsApplication PCTUS2003015498Pending
- Hybridization Device And MethodApplication PCTUS2003002486Pending
- Real-time Monitoring Of Pcr Amplification Using Nanoparticle ProbesApplication PCTUS2002038069Pending
- Bioconjugate-nanoparticle ProbesApplication PCTUS2002035888Pending
- Nanoparticles Having Oligonucleotides Attached Thereto And Uses ThereforApplication PCTUS2002032088Pending
- Nanoparticle Imaging System And MethodApplication PCTUS2002024604Pending
- Oligonucleotide-modified Romp Polymers And Co-polymersApplication PCTUS2002012071Pending
- Nanoparticles Having Oligonucleotides Attached Thereto And Uses ThereofApplication PCTUS2001046418Pending
- Methods Of Treating Inflammatory Disorders And Global Inflammation With Compositions Comprising Phospholipid Nanoparticle Encapsulations Of NsaidsApplication PCTUS2015065611Pending
- Lipid Nanoparticle Compositions And Methods As Carriers Of Cannabinoids In Standardized Precision-metered Dosage FormsApplication PCTUS2015034153Pending
- Lipid Nanoparticle Compositions and Methods as Carriers of CannabinoidsApplication 62130775Pending
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .